Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentan

BACKGROUND: Axonal degeneration is related to long-term disability in patients with multiple sclerosis (MS). The underlying mechanism remains ill understood but appears to involve axonal energetic dysfunction. A globally impaired cerebral blood flow (CBF) has been observed in the normal-appearing wh...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Trials
Autori principali: Hostenbach, Stéphanie, Pauwels, Ayla, Michiels, Veronique, Raeymaekers, Hubert, Van Binst, Anne-Marie, Van Merhaeghen-Wieleman, Annick, Van Schuerbeek, Peter, De Keyser, Jacques, D’Haeseleer, Miguel
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6416892/
https://ncbi.nlm.nih.gov/pubmed/30871594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3252-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi